Why the study?
Does autonomic block exaggerate drug-induced QT prolongation by ibutilide in healthy adults?
Does autonomic block exaggerate drug-induced QT prolongation by ibutilide in healthy adults?
Autonomic block exaggerates drug-induced QT prolongation, suggesting that QT-prolonging drugs may pose a higher risk of sudden death in patients with underlying autonomic dysfunction.
Autonomic block exaggerates ibutilide QTc prolongation; leaves open whether this increases arrhythmic risk in autonomic dysfunction.
INTRODUCTION: The QT interval is a predictor of sudden death. Many drugs prolong the QT, primarily through I(Kr) block. Autonomic tone directly affects heart rate and ventricular repolarization, but its effects in the setting of I(Kr) block are unknown. OBJECTIVE: Determine the effects of autonomic tone on heart rate and QT interval after I(Kr) block. METHODS AND RESULTS: Healthy adults (n = 9) were administered ibutilide with ECGs obtained at regular intervals. On a separate day, subjects were administered intravenous propranolol and atropine to induce autonomic block, resulting in intrinsic heart rate and QT interval; ibutilide was administered again, with serial ECGs obtained at regular intervals. No differences in baseline RR, QT, or QTc intervals were seen between the two study days. Ibutilide in the setting of intact autonomic tone prolonged QTc by 43 +/- 8 msec (P = 0.001) and prolonged RR interval by 93 +/- 39 msec (P = 0.04). Autonomic block alone on the second day prolonged QTc by 16.7 +/- 9.4 msec (P = 0.02). An additional 68 +/- 5 msec prolongation of QTc was seen with ibutilide in the setting of double autonomic block (P = 0.036). There was no effect of ibutilide on intrinsic heart rate (P = 0.125). CONCLUSION: Autonomic block results in an exaggeration of drug-induced QT prolongation by ibutilide. I(Kr) block has no effect on intrinsic heart rate. QT-prolonging drugs may have more deleterious effects in those with underlying autonomic dysfunction, thus increasing the risk for sudden death.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: